메뉴 건너뛰기




Volumn 51, Issue 9, 2010, Pages 1480-1485

Whole-body biodistribution and radiation dosimetry of 18F-FP-(+) -DTBZ (18F-AV-133): A novel vesicular monoamine transporter 2 imaging agent

Author keywords

Dosimetry; Parkinson disease; PET; Vesicular monoamine transporter 2; Whole body biodistribution

Indexed keywords

9 (3 FLUOROPROPOXY) 3 ISOBUTYL 10 METHOXY 2,3,4,6,7,11B HEXAHYDRO 1H PYRIDO[2,1 A]ISOQUINOLIN 2 OL F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; 9 FLUOROPROPYLDIHYDROTETRABENAZINE; 9-FLUOROPROPYLDIHYDROTETRABENAZINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; TETRABENAZINE; VESICULAR MONOAMINE TRANSPORTER;

EID: 77957028183     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.078196     Document Type: Article
Times cited : (55)

References (36)
  • 1
    • 33644948128 scopus 로고    scopus 로고
    • Rapid loss of striatal VMAT2 binding associated with onset of Lewy body dementia
    • Albin R, Koeppe R. Rapid loss of striatal VMAT2 binding associated with onset of Lewy body dementia. Mov Disord. 2006;21:287-288.
    • (2006) Mov Disord , vol.21 , pp. 287-288
    • Albin, R.1    Koeppe, R.2
  • 2
    • 0030796597 scopus 로고    scopus 로고
    • In vivo radiotracers for vesicular neurotransmitter transporters
    • Kilbourn MR. In vivo radiotracers for vesicular neurotransmitter transporters. Nucl Med Biol. 1997;24:615-619.
    • (1997) Nucl Med Biol , vol.24 , pp. 615-619
    • Kilbourn, M.R.1
  • 3
    • 19944432710 scopus 로고    scopus 로고
    • The role of radiotracer imaging in Parkinson disease
    • Ravina B, Eidelberg D, Ahlskog JE, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 2005;64:208-215.
    • (2005) Neurology , vol.64 , pp. 208-215
    • Ravina, B.1    Eidelberg, D.2    Ahlskog, J.E.3
  • 4
    • 33645993639 scopus 로고    scopus 로고
    • Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis
    • Van Laere K, Casteels C, De CL, et al. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis. J Nucl Med. 2006;47:384-392.
    • (2006) J Nucl Med , vol.47 , pp. 384-392
    • Van Laere, K.1    Casteels, C.2    De, C.L.3
  • 5
    • 0033625124 scopus 로고    scopus 로고
    • 99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers
    • 99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. J Nucl Med. 2000;41:584-589.
    • (2000) J Nucl Med , vol.41 , pp. 584-589
    • Mozley, P.D.1    Schneider, J.S.2    Acton, P.D.3
  • 6
    • 0037208654 scopus 로고    scopus 로고
    • Dopamine receptors in Parkinson's disease: Imaging studies
    • Stoessl AJ. de lF-F. Dopamine receptors in Parkinson's disease: imaging studies. Adv Neurol. 2003;91:65-71.
    • (2003) Adv Neurol , vol.91 , pp. 65-71
    • Stoessl, A.J.D.L.F.-F.1
  • 7
    • 0035237282 scopus 로고    scopus 로고
    • Imaging the vesicular monoamine transporter
    • Frey KA, Koeppe RA, Kilbourn MR. Imaging the vesicular monoamine transporter. Adv Neurol. 2001;86:237-247.
    • (2001) Adv Neurol , vol.86 , pp. 237-247
    • Frey, K.A.1    Koeppe, R.A.2    Kilbourn, M.R.3
  • 8
    • 0030511826 scopus 로고    scopus 로고
    • Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging
    • Frey KA, Koeppe RA, Kilbourn MR, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol. 1996;40:873-884.
    • (1996) Ann Neurol , vol.40 , pp. 873-884
    • Frey, K.A.1    Koeppe, R.A.2    Kilbourn, M.R.3
  • 9
    • 0042125047 scopus 로고    scopus 로고
    • Increased ventral striatal monoaminergic innervation in Tourette syndrome
    • Albin RL, Koeppe RA, Bohnen NI, et al. Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology. 2003;61:310-315.
    • (2003) Neurology , vol.61 , pp. 310-315
    • Albin, R.L.1    Koeppe, R.A.2    Bohnen, N.I.3
  • 10
    • 33747348188 scopus 로고    scopus 로고
    • Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease
    • Bohnen NI, Albin RL, Koeppe RA, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006;26:1198-1212.
    • (2006) J Cereb Blood Flow Metab , vol.26 , pp. 1198-1212
    • Bohnen, N.I.1    Albin, R.L.2    Koeppe, R.A.3
  • 11
    • 0036583564 scopus 로고    scopus 로고
    • Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease?
    • Frey KA. Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? Eur J Nucl Med Mol Imaging. 2002;29:715-717.
    • (2002) Eur J Nucl Med Mol Imaging , vol.29 , pp. 715-717
    • Frey, K.A.1
  • 12
    • 10044247418 scopus 로고    scopus 로고
    • Lack of regional selectivity during the progression of Parkinson disease: Implications for pathogenesis
    • Lee CS, Schulzer M, de la Fuente-Fernández R, et al. Lack of regional selectivity during the progression of Parkinson disease: implications for pathogenesis. Arch Neurol. 2004;61:1920-1925.
    • (2004) Arch Neurol , vol.61 , pp. 1920-1925
    • Lee, C.S.1    Schulzer, M.2    De La Fuente-Fernández, R.3
  • 13
    • 0030152867 scopus 로고    scopus 로고
    • Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters
    • Kilbourn MR, Frey KA, Vander BT, Sherman PS. Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transporters. Nucl Med Biol. 1996;23:467-471.
    • (1996) Nucl Med Biol , vol.23 , pp. 467-471
    • Kilbourn, M.R.1    Frey, K.A.2    Vander, B.T.3    Sherman, P.S.4
  • 14
    • 0033966874 scopus 로고    scopus 로고
    • Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice
    • Kilbourn MR, Kuszpit K, Sherman P. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Synapse. 2000;35:250-255.
    • (2000) Synapse , vol.35 , pp. 250-255
    • Kilbourn, M.R.1    Kuszpit, K.2    Sherman, P.3
  • 15
    • 33747354108 scopus 로고    scopus 로고
    • Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters
    • Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Nucl Med Biol. 2006;33: 685-694.
    • (2006) Nucl Med Biol , vol.33 , pp. 685-694
    • Goswami, R.1    Ponde, D.E.2    Kung, M.P.3    Hou, C.4    Kilbourn, M.R.5    Kung, H.F.6
  • 16
    • 33947305764 scopus 로고    scopus 로고
    • Characterization of optically resolved 9-fluoropropyl- dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters
    • Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nucl Med Biol. 2007;34:239-246.
    • (2007) Nucl Med Biol , vol.34 , pp. 239-246
    • Kung, M.P.1    Hou, C.2    Goswami, R.3    Ponde, D.E.4    Kilbourn, M.R.5    Kung, H.F.6
  • 17
    • 33947319832 scopus 로고    scopus 로고
    • 18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain
    • 18F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol. 2007;34:233-237.
    • (2007) Nucl Med Biol , vol.34 , pp. 233-237
    • Kilbourn, M.R.1    Hockley, B.2    Lee, L.3
  • 19
    • 0036266804 scopus 로고    scopus 로고
    • Striatal monoaminergic terminals in lewy body and Alzheimer's dementias
    • DOI 10.1002/ana.10186
    • Suzuki M, Desmond TJ, Albin RL, Frey KA. Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Ann Neurol. 2002;51:767-771. (Pubitemid 34568857)
    • (2002) Annals of Neurology , vol.51 , Issue.6 , pp. 767-771
    • Suzuki, M.1    Desmond, T.J.2    Albin, R.L.3    Frey, K.A.4
  • 21
    • 77952552594 scopus 로고    scopus 로고
    • 18F]AV-45, a novel amyloid imaging agent: A pilot study
    • 18F]AV-45, a novel amyloid imaging agent: a pilot study. Nucl Med Biol. 2010;37:497-508.
    • (2010) Nucl Med Biol , vol.37 , pp. 497-508
    • Lin, K.J.1    Hsu, W.C.2    Hsiao, I.T.3
  • 22
    • 23044470017 scopus 로고    scopus 로고
    • OLINDA/EXM: The second-generation personal computer software for internal dose assessment in nuclear medicine
    • Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
    • (2005) J Nucl Med , vol.46 , pp. 1023-1027
    • Stabin, M.G.1    Sparks, R.B.2    Crowe, E.3
  • 23
    • 0003733260 scopus 로고
    • International Commission on Radiological Protection (ICRP). ICRP Publication 60. New York, NY: Pergamon Press
    • International Commission on Radiological Protection (ICRP). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. New York, NY: Pergamon Press; 1991.
    • (1991) 1990 Recommendations of the International Commission on Radiological Protection
  • 24
    • 33644939201 scopus 로고    scopus 로고
    • Brain SPECT imaging and whole-body biodistribution with [123I]A
    • Lin KJ, Liu CY, Wey SP, et al. Brain SPECT imaging and whole-body biodistribution with [123I]A. Nucl Med Biol. 2006;33:193-202.
    • (2006) Nucl Med Biol , vol.33 , pp. 193-202
    • Lin, K.J.1    Liu, C.Y.2    Wey, S.P.3
  • 26
    • 0003618858 scopus 로고
    • International Commission on Radiological Protection (ICRP). ICRP Publication 30. Oxford, U.K.: Pergamon Press
    • International Commission on Radiological Protection (ICRP). Part 1: Limits for Intakes of Radionuclides by Workers. ICRP Publication 30. Oxford, U.K.: Pergamon Press; 1979.
    • (1979) Part 1: Limits for Intakes of Radionuclides by Workers
  • 29
    • 0029562331 scopus 로고
    • PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics (SPCs)
    • Meyer GJ, Waters SL, Coenen HH, Luxen A, Maziere B, Langstrom B. PET radiopharmaceuticals in Europe: current use and data relevant for the formulation of summaries of product characteristics (SPCs). Eur J Nucl Med. 1995;22:1420-1432.
    • (1995) Eur J Nucl Med , vol.22 , pp. 1420-1432
    • Meyer, G.J.1    Waters, S.L.2    Coenen, H.H.3    Luxen, A.4    Maziere, B.5    Langstrom, B.6
  • 30
    • 0022647428 scopus 로고
    • The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders
    • Roberts MS, McLean S, Millingen KS, Galloway HM. The pharmacokinetics of tetrabenazine and its hydroxy metabolite in patients treated for involuntary movement disorders. Eur J Clin Pharmacol. 1986;29:703-708.
    • (1986) Eur J Clin Pharmacol , vol.29 , pp. 703-708
    • Roberts, M.S.1    McLean, S.2    Millingen, K.S.3    Galloway, H.M.4
  • 31
    • 0023093007 scopus 로고
    • Pharmacokinetics of tetrabenazine and its major metabolite in man and rat. Bioavailability and dose dependency studies
    • Mehvar R, Jamali F, Watson MW, Skelton D. Pharmacokinetics of tetrabenazine and its major metabolite in man and rat: bioavailability and dose dependency studies. Drug Metab Dispos. 1987;15:250-255. (Pubitemid 17056771)
    • (1987) Drug Metabolism and Disposition , vol.15 , Issue.2 , pp. 250-255
    • Mehvar, R.1    Jamali, F.2    Watson, W.B.3    Skelton, D.4
  • 32
    • 40949132162 scopus 로고    scopus 로고
    • 11C]-dihydrotetrabenazine imaging of baboons: Biodistribution and human radiation dosimetry estimates
    • 11C]- dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging. 2008;35:790-797.
    • (2008) Eur J Nucl Med Mol Imaging , vol.35 , pp. 790-797
    • Murthy, R.1    Harris, P.2    Simpson, N.3
  • 33
    • 46749097973 scopus 로고    scopus 로고
    • 18F-FP-(+)- DTBZ: A potential PET ligand for studying diabetes mellitus
    • 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med. 2008;49:1171-1176.
    • (2008) J Nucl Med , vol.49 , pp. 1171-1176
    • Kung, M.P.1    Hou, C.2    Lieberman, B.P.3
  • 34
    • 0042244323 scopus 로고    scopus 로고
    • Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors
    • Anlauf M, Eissele R, Schafer MK, et al. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors. J Histochem Cytochem. 2003;51:1027-1040.
    • (2003) J Histochem Cytochem , vol.51 , pp. 1027-1040
    • Anlauf, M.1    Eissele, R.2    Schafer, M.K.3
  • 35
    • 77952551571 scopus 로고    scopus 로고
    • Binding characteristics of 9-fluoropropyl- (+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats
    • Tsao HH, Lin KJ, Juang JH, et al. Binding characteristics of 9-fluoropropyl- (+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats. Nucl Med Biol. 2010;37:413-419.
    • (2010) Nucl Med Biol , vol.37 , pp. 413-419
    • Tsao, H.H.1    Lin, K.J.2    Juang, J.H.3
  • 36
    • 0033668692 scopus 로고    scopus 로고
    • Chemical neuroanatomy of the vesicular amine transporters
    • Weihe E, Eiden LE. Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 2000;14:2435-2449.
    • (2000) FASEB J , vol.14 , pp. 2435-2449
    • Weihe, E.1    Eiden, L.E.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.